Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients : Identification of Associated Factors Using Electronic Health Records and Natural Language Processing
Patients with Type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) are at high risk of developing major adverse cardiovascular events (MACE). This is a multicenter, retrospective, and observational study performed in Spain aimed to characterize these patients in a real-world setting. Unstructured data from the Electronic Health Records were extracted by EHRead®, a technology based on Natural Language Processing and machine learning. The association between new MACE and the variables of interest were investigated by univariable and multivariable analyses. From a source population of 2,184,662 patients, we identified 4072 adults diagnosed with T2DM and CAD (62.2% male, mean age 70 ± 11). The main comorbidities observed included arterial hypertension, hyperlipidemia, and obesity, with metformin and statins being the treatments most frequently prescribed. MACE development was associated with multivessel (Hazard Ratio (HR) = 2.49) and single coronary vessel disease (HR = 1.71), transient ischemic attack (HR = 2.01), heart failure (HR = 1.32), insulin treatment (HR = 1.40), and percutaneous coronary intervention (PCI) (HR = 2.27), whilst statins (HR = 0.73) were associated with a lower risk of MACE occurrence. In conclusion, we found six risk factors associated with the development of MACE which were related with cardiovascular diseases and T2DM severity, and treatment with statins was identified as a protective factor for new MACE in this study.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Journal of clinical medicine - 11(2022), 20 vom: 11. Okt. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
González-Juanatey, Carlos [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Coronary artery disease |
|---|
| Anmerkungen: |
Date Revised 30.10.2022 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3390/jcm11206004 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM348087306 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM348087306 | ||
| 003 | DE-627 | ||
| 005 | 20231226035350.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/jcm11206004 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1160.xml |
| 035 | |a (DE-627)NLM348087306 | ||
| 035 | |a (NLM)36294325 | ||
| 035 | |a (PII)6004 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a González-Juanatey, Carlos |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients |b Identification of Associated Factors Using Electronic Health Records and Natural Language Processing |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 30.10.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Patients with Type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) are at high risk of developing major adverse cardiovascular events (MACE). This is a multicenter, retrospective, and observational study performed in Spain aimed to characterize these patients in a real-world setting. Unstructured data from the Electronic Health Records were extracted by EHRead®, a technology based on Natural Language Processing and machine learning. The association between new MACE and the variables of interest were investigated by univariable and multivariable analyses. From a source population of 2,184,662 patients, we identified 4072 adults diagnosed with T2DM and CAD (62.2% male, mean age 70 ± 11). The main comorbidities observed included arterial hypertension, hyperlipidemia, and obesity, with metformin and statins being the treatments most frequently prescribed. MACE development was associated with multivessel (Hazard Ratio (HR) = 2.49) and single coronary vessel disease (HR = 1.71), transient ischemic attack (HR = 2.01), heart failure (HR = 1.32), insulin treatment (HR = 1.40), and percutaneous coronary intervention (PCI) (HR = 2.27), whilst statins (HR = 0.73) were associated with a lower risk of MACE occurrence. In conclusion, we found six risk factors associated with the development of MACE which were related with cardiovascular diseases and T2DM severity, and treatment with statins was identified as a protective factor for new MACE in this study | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a MACE | |
| 650 | 4 | |a coronary artery disease | |
| 650 | 4 | |a diabetes mellitus | |
| 650 | 4 | |a electronic health records | |
| 650 | 4 | |a natural language processing | |
| 650 | 4 | |a risk factors | |
| 700 | 1 | |a Anguita-Sánchez, Manuel |e verfasserin |4 aut | |
| 700 | 1 | |a Barrios, Vivencio |e verfasserin |4 aut | |
| 700 | 1 | |a Núñez-Gil, Iván |e verfasserin |4 aut | |
| 700 | 1 | |a Gómez-Doblas, Juan José |e verfasserin |4 aut | |
| 700 | 1 | |a García-Moll, Xavier |e verfasserin |4 aut | |
| 700 | 1 | |a Lafuente-Gormaz, Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Rollán-Gómez, María Jesús |e verfasserin |4 aut | |
| 700 | 1 | |a Peral-Disdier, Vicente |e verfasserin |4 aut | |
| 700 | 1 | |a Martínez-Dolz, Luis |e verfasserin |4 aut | |
| 700 | 1 | |a Rodríguez-Santamarta, Miguel |e verfasserin |4 aut | |
| 700 | 1 | |a Viñolas-Prat, Xavier |e verfasserin |4 aut | |
| 700 | 1 | |a Soriano-Colomé, Toni |e verfasserin |4 aut | |
| 700 | 1 | |a Muñoz-Aguilera, Roberto |e verfasserin |4 aut | |
| 700 | 1 | |a Plaza, Ignacio |e verfasserin |4 aut | |
| 700 | 1 | |a Curcio-Ruigómez, Alejandro |e verfasserin |4 aut | |
| 700 | 1 | |a Orts-Soler, Ernesto |e verfasserin |4 aut | |
| 700 | 1 | |a Segovia, Javier |e verfasserin |4 aut | |
| 700 | 1 | |a Fanjul, Víctor |e verfasserin |4 aut | |
| 700 | 1 | |a Cequier, Ángel |e verfasserin |4 aut | |
| 700 | 1 | |a Savana Research Group |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical medicine |d 2012 |g 11(2022), 20 vom: 11. Okt. |w (DE-627)NLM230666310 |x 2077-0383 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2022 |g number:20 |g day:11 |g month:10 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/jcm11206004 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2022 |e 20 |b 11 |c 10 | ||